Publication identifier(s): 8702946
A surface coat protein involved in immune evasion in Leishmaniids. Extremely fast evolving, almost completely disordered mucin-like protein. . Localization: Cell surface (experimental)
                
                    by homology
Contact email: handman@wehi.edu.au
Publication title: A Leucine-Rich Repeat Motif of Leishmania Parasite Surface Antigen 2 Binds to Macrophages through the Complement Receptor 3
Publication 1st author(s): Kedzierski
Publication Identifier(s): 15067069
Host organism: -1
Interaction detection method(s): fluorescence activated cell sorting
Interaction type: physical association
Identification method participant A: identification by antibody
Identification method participant B: identification by antibody
ID(s) interactor A: P11215
ID(s) interactor B: E9AGG4
Taxid interactor A: Homo sapiens
Taxid interactor B: Leishmania infantum
Biological role(s) interactor A: unspecified role
Biological role(s) interactor B: unspecified role
Experimental role(s) interactor A: unspecified role
                
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 165 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 7 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 14 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | yes | yes: 65, no: 9 | 
| NetGPI | no | yes: 0, no: 74 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0005929 | cilium | 4 | 75 | 
| GO:0016020 | membrane | 2 | 26 | 
| GO:0042995 | cell projection | 2 | 75 | 
| GO:0043226 | organelle | 2 | 75 | 
| GO:0043227 | membrane-bounded organelle | 3 | 75 | 
| GO:0110165 | cellular anatomical entity | 1 | 75 | 
| GO:0120025 | plasma membrane bounded cell projection | 3 | 75 | 
| GO:0005886 | plasma membrane | 3 | 5 | 
Related structures:
AlphaFold database: Q4QGL4
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 3 | 
| GO:0004672 | protein kinase activity | 3 | 3 | 
| GO:0004674 | protein serine/threonine kinase activity | 4 | 3 | 
| GO:0016301 | kinase activity | 4 | 3 | 
| GO:0016740 | transferase activity | 2 | 3 | 
| GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 3 | 
| GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 3 | 
| GO:0140096 | catalytic activity, acting on a protein | 2 | 3 | 
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 124 | 128 | PF00656 | 0.336 | 
| CLV_NRD_NRD_1 | 205 | 207 | PF00675 | 0.419 | 
| CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.720 | 
| CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.687 | 
| CLV_PCSK_SKI1_1 | 206 | 210 | PF00082 | 0.457 | 
| CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.653 | 
| DOC_AGCK_PIF_2 | 69 | 74 | PF00069 | 0.222 | 
| DOC_CYCLIN_RxL_1 | 105 | 116 | PF00134 | 0.234 | 
| DOC_CYCLIN_RxL_1 | 3 | 13 | PF00134 | 0.442 | 
| DOC_MAPK_gen_1 | 203 | 213 | PF00069 | 0.281 | 
| DOC_MAPK_MEF2A_6 | 301 | 308 | PF00069 | 0.300 | 
| DOC_PP1_RVXF_1 | 108 | 115 | PF00149 | 0.238 | 
| DOC_USP7_MATH_1 | 371 | 375 | PF00917 | 0.406 | 
| DOC_USP7_MATH_2 | 223 | 229 | PF00917 | 0.253 | 
| DOC_USP7_MATH_2 | 271 | 277 | PF00917 | 0.293 | 
| DOC_WW_Pin1_4 | 85 | 90 | PF00397 | 0.351 | 
| LIG_14-3-3_CanoR_1 | 206 | 213 | PF00244 | 0.264 | 
| LIG_14-3-3_CanoR_1 | 281 | 286 | PF00244 | 0.278 | 
| LIG_14-3-3_CanoR_1 | 43 | 48 | PF00244 | 0.433 | 
| LIG_Actin_WH2_2 | 177 | 192 | PF00022 | 0.207 | 
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.591 | 
| LIG_BRCT_BRCA1_1 | 70 | 74 | PF00533 | 0.241 | 
| LIG_deltaCOP1_diTrp_1 | 62 | 69 | PF00928 | 0.393 | 
| LIG_FHA_1 | 207 | 213 | PF00498 | 0.267 | 
| LIG_FHA_1 | 317 | 323 | PF00498 | 0.307 | 
| LIG_FHA_1 | 42 | 48 | PF00498 | 0.392 | 
| LIG_FHA_2 | 122 | 128 | PF00498 | 0.329 | 
| LIG_FHA_2 | 155 | 161 | PF00498 | 0.325 | 
| LIG_FHA_2 | 323 | 329 | PF00498 | 0.318 | 
| LIG_FHA_2 | 92 | 98 | PF00498 | 0.383 | 
| LIG_LIR_Gen_1 | 113 | 121 | PF02991 | 0.364 | 
| LIG_LIR_Gen_1 | 127 | 135 | PF02991 | 0.346 | 
| LIG_LIR_Gen_1 | 152 | 159 | PF02991 | 0.315 | 
| LIG_LIR_Gen_1 | 231 | 242 | PF02991 | 0.264 | 
| LIG_LIR_Gen_1 | 273 | 280 | PF02991 | 0.321 | 
| LIG_LIR_Gen_1 | 71 | 80 | PF02991 | 0.259 | 
| LIG_LIR_Nem_3 | 103 | 107 | PF02991 | 0.407 | 
| LIG_LIR_Nem_3 | 127 | 132 | PF02991 | 0.366 | 
| LIG_LIR_Nem_3 | 231 | 237 | PF02991 | 0.259 | 
| LIG_LIR_Nem_3 | 255 | 261 | PF02991 | 0.317 | 
| LIG_LIR_Nem_3 | 71 | 75 | PF02991 | 0.281 | 
| LIG_PDZ_Class_2 | 390 | 395 | PF00595 | 0.235 | 
| LIG_PTAP_UEV_1 | 323 | 328 | PF05743 | 0.303 | 
| LIG_SH2_STAT3 | 238 | 241 | PF00017 | 0.240 | 
| LIG_SH2_STAT5 | 234 | 237 | PF00017 | 0.217 | 
| LIG_SH2_STAT5 | 238 | 241 | PF00017 | 0.237 | 
| LIG_SH2_STAT5 | 258 | 261 | PF00017 | 0.284 | 
| LIG_SH2_STAT5 | 354 | 357 | PF00017 | 0.390 | 
| LIG_SH3_1 | 321 | 327 | PF00018 | 0.299 | 
| LIG_SH3_3 | 321 | 327 | PF00018 | 0.338 | 
| LIG_SH3_3 | 93 | 99 | PF00018 | 0.387 | 
| LIG_Sin3_3 | 379 | 386 | PF02671 | 0.206 | 
| LIG_SUMO_SIM_anti_2 | 182 | 188 | PF11976 | 0.259 | 
| LIG_SUMO_SIM_anti_2 | 46 | 51 | PF11976 | 0.357 | 
| LIG_SUMO_SIM_par_1 | 304 | 310 | PF11976 | 0.259 | 
| LIG_TYR_ITIM | 102 | 107 | PF00017 | 0.445 | 
| LIG_TYR_ITIM | 232 | 237 | PF00017 | 0.258 | 
| MOD_CK1_1 | 152 | 158 | PF00069 | 0.357 | 
| MOD_CK1_1 | 179 | 185 | PF00069 | 0.283 | 
| MOD_CK1_1 | 228 | 234 | PF00069 | 0.280 | 
| MOD_CK1_1 | 251 | 257 | PF00069 | 0.343 | 
| MOD_CK1_1 | 315 | 321 | PF00069 | 0.319 | 
| MOD_CK2_1 | 127 | 133 | PF00069 | 0.304 | 
| MOD_CK2_1 | 154 | 160 | PF00069 | 0.406 | 
| MOD_CK2_1 | 322 | 328 | PF00069 | 0.315 | 
| MOD_CK2_1 | 91 | 97 | PF00069 | 0.421 | 
| MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.578 | 
| MOD_GlcNHglycan | 140 | 143 | PF01048 | 0.453 | 
| MOD_GlcNHglycan | 145 | 148 | PF01048 | 0.506 | 
| MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.474 | 
| MOD_GlcNHglycan | 194 | 197 | PF01048 | 0.496 | 
| MOD_GlcNHglycan | 218 | 221 | PF01048 | 0.533 | 
| MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.572 | 
| MOD_GlcNHglycan | 249 | 253 | PF01048 | 0.534 | 
| MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.685 | 
| MOD_GlcNHglycan | 265 | 269 | PF01048 | 0.528 | 
| MOD_GlcNHglycan | 285 | 288 | PF01048 | 0.487 | 
| MOD_GlcNHglycan | 342 | 345 | PF01048 | 0.661 | 
| MOD_GlcNHglycan | 374 | 377 | PF01048 | 0.238 | 
| MOD_GSK3_1 | 121 | 128 | PF00069 | 0.351 | 
| MOD_GSK3_1 | 134 | 141 | PF00069 | 0.274 | 
| MOD_GSK3_1 | 154 | 161 | PF00069 | 0.322 | 
| MOD_GSK3_1 | 176 | 183 | PF00069 | 0.331 | 
| MOD_GSK3_1 | 312 | 319 | PF00069 | 0.390 | 
| MOD_GSK3_1 | 32 | 39 | PF00069 | 0.537 | 
| MOD_GSK3_1 | 322 | 329 | PF00069 | 0.486 | 
| MOD_GSK3_1 | 354 | 361 | PF00069 | 0.436 | 
| MOD_GSK3_1 | 87 | 94 | PF00069 | 0.376 | 
| MOD_N-GLC_2 | 262 | 264 | PF02516 | 0.403 | 
| MOD_NEK2_1 | 10 | 15 | PF00069 | 0.552 | 
| MOD_NEK2_1 | 121 | 126 | PF00069 | 0.338 | 
| MOD_NEK2_1 | 138 | 143 | PF00069 | 0.282 | 
| MOD_NEK2_1 | 189 | 194 | PF00069 | 0.261 | 
| MOD_NEK2_1 | 21 | 26 | PF00069 | 0.504 | 
| MOD_NEK2_1 | 213 | 218 | PF00069 | 0.256 | 
| MOD_NEK2_1 | 237 | 242 | PF00069 | 0.294 | 
| MOD_NEK2_1 | 266 | 271 | PF00069 | 0.302 | 
| MOD_NEK2_1 | 283 | 288 | PF00069 | 0.241 | 
| MOD_NEK2_2 | 134 | 139 | PF00069 | 0.212 | 
| MOD_PIKK_1 | 237 | 243 | PF00454 | 0.220 | 
| MOD_PK_1 | 166 | 172 | PF00069 | 0.225 | 
| MOD_PKA_1 | 206 | 212 | PF00069 | 0.210 | 
| MOD_PKA_2 | 189 | 195 | PF00069 | 0.315 | 
| MOD_Plk_1 | 272 | 278 | PF00069 | 0.324 | 
| MOD_Plk_1 | 358 | 364 | PF00069 | 0.405 | 
| MOD_Plk_2-3 | 160 | 166 | PF00069 | 0.350 | 
| MOD_Plk_2-3 | 68 | 74 | PF00069 | 0.365 | 
| MOD_Plk_4 | 182 | 188 | PF00069 | 0.330 | 
| MOD_Plk_4 | 213 | 219 | PF00069 | 0.318 | 
| MOD_ProDKin_1 | 85 | 91 | PF00069 | 0.348 | 
| TRG_DiLeu_BaEn_1 | 359 | 364 | PF01217 | 0.256 | 
| TRG_ENDOCYTIC_2 | 104 | 107 | PF00928 | 0.448 | 
| TRG_ENDOCYTIC_2 | 234 | 237 | PF00928 | 0.209 | 
| TRG_ENDOCYTIC_2 | 258 | 261 | PF00928 | 0.338 | 
| TRG_ER_diArg_1 | 5 | 7 | PF00400 | 0.664 | 
| TRG_Pf-PMV_PEXEL_1 | 206 | 210 | PF00026 | 0.409 | 
| TRG_Pf-PMV_PEXEL_1 | 55 | 59 | PF00026 | 0.466 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N0P2L4 | Leptomonas seymouri | 35% | 100% | 
| A0A0N1I121 | Leptomonas seymouri | 30% | 79% | 
| A0A0N1I7S5 | Leptomonas seymouri | 35% | 78% | 
| A0A0S4IQ67 | Bodo saltans | 25% | 100% | 
| A0A0S4IQE4 | Bodo saltans | 22% | 70% | 
| A0A0S4IR61 | Bodo saltans | 29% | 98% | 
| A0A0S4JD35 | Bodo saltans | 28% | 66% | 
| A0A0S4JFC9 | Bodo saltans | 27% | 82% | 
| A0A0S4JFV3 | Bodo saltans | 24% | 100% | 
| A0A0S4JHM1 | Bodo saltans | 27% | 100% | 
| A0A0S4JQW3 | Bodo saltans | 26% | 100% | 
| A0A0S4KMV2 | Bodo saltans | 28% | 100% | 
| A0A3Q8I9A6 | Leishmania donovani | 59% | 100% | 
| A0A3Q8I9D0 | Leishmania donovani | 61% | 100% | 
| A0A3Q8IC27 | Leishmania donovani | 36% | 83% | 
| A0A3Q8IFC2 | Leishmania donovani | 40% | 91% | 
| A0A3Q8IIJ9 | Leishmania donovani | 35% | 100% | 
| A0A3Q8IK15 | Leishmania donovani | 33% | 75% | 
| A0A3S5H6D6 | Leishmania donovani | 30% | 100% | 
| A0A3S5H6L9 | Leishmania donovani | 59% | 68% | 
| A0A3S7WP69 | Leishmania donovani | 22% | 96% | 
| A0A3S7WPB2 | Leishmania donovani | 28% | 100% | 
| A0A3S7X4J4 | Leishmania donovani | 35% | 100% | 
| A4H4G6 | Leishmania braziliensis | 26% | 100% | 
| A4H5P0 | Leishmania braziliensis | 31% | 100% | 
| A4HBX3 | Leishmania braziliensis | 34% | 87% | 
| A4HJC8 | Leishmania braziliensis | 32% | 100% | 
| A4HJX1 | Leishmania braziliensis | 36% | 90% | 
| A4HSL2 | Leishmania infantum | 22% | 96% | 
| A4HTX9 | Leishmania infantum | 31% | 100% | 
| A4HVB0 | Leishmania infantum | 52% | 98% | 
| A4HZ93 | Leishmania infantum | 36% | 83% | 
| A4I6S2 | Leishmania infantum | 32% | 90% | 
| A4I6S3 | Leishmania infantum | 39% | 79% | 
| A4I6S4 | Leishmania infantum | 35% | 100% | 
| D1GJ51 | Leishmania infantum | 60% | 85% | 
| E8NHG5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 37% | 89% | 
| E8NHP8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 100% | 
| E9ACQ0 | Leishmania major | 28% | 100% | 
| E9AEF4 | Leishmania major | 38% | 86% | 
| E9AG65 | Leishmania infantum | 28% | 100% | 
| E9AGG5 | Leishmania infantum | 55% | 95% | 
| E9AGG9 | Leishmania infantum | 56% | 73% | 
| E9AGH0 | Leishmania infantum | 64% | 100% | 
| E9AKJ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 22% | 100% | 
| E9AKM8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% | 
| E9AMQ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 100% | 
| E9AP00 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 100% | 
| E9AP02 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 55% | 100% | 
| E9AP03 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 61% | 100% | 
| E9AP05 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 51% | 77% | 
| E9AP07 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 56% | 100% | 
| E9AP08 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 55% | 94% | 
| E9AVA1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 36% | 86% | 
| E9B1U3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 87% | 
| E9B1U4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 100% | 
| E9B1U5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 37% | 94% | 
| E9B1U6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 100% | 
| P21978 | Leishmania amazonensis | 42% | 83% | 
| Q05091 | Pyrus communis | 23% | 100% | 
| Q25331 | Leishmania major | 63% | 94% | 
| Q4PSE6 | Arabidopsis thaliana | 25% | 91% | 
| Q4Q6B6 | Leishmania major | 33% | 100% | 
| Q4Q6B7 | Leishmania major | 33% | 100% | 
| Q4Q6B8 | Leishmania major | 34% | 75% | 
| Q4QC79 | Leishmania major | 33% | 100% | 
| Q4QGI0 | Leishmania major | 63% | 78% | 
| Q4QGI2 | Leishmania major | 52% | 71% | 
| Q4QGI4 | Leishmania major | 52% | 74% | 
| Q4QGI6 | Leishmania major | 65% | 72% | 
| Q4QGJ4 | Leishmania major | 62% | 94% | 
| Q4QGJ6 | Leishmania major | 69% | 69% | 
| Q4QGJ7 | Leishmania major | 63% | 84% | 
| Q4QGJ9 | Leishmania major | 68% | 67% | 
| Q4QGK0 | Leishmania major | 70% | 69% | 
| Q4QGK2 | Leishmania major | 50% | 71% | 
| Q4QGK6 | Leishmania major | 60% | 84% | 
| Q4QGK8 | Leishmania major | 51% | 77% | 
| Q4QGL2 | Leishmania major | 51% | 77% | 
| Q4QGL5 | Leishmania major | 65% | 72% | 
| Q4QHW6 | Leishmania major | 30% | 100% | 
| Q4QJB2 | Leishmania major | 22% | 100% | 
| Q8GT95 | Oryza sativa subsp. japonica | 23% | 100% | 
| Q8W3M4 | Arabidopsis thaliana | 24% | 98% | 
| Q9LHF1 | Arabidopsis thaliana | 23% | 80% |